21259 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
#902Liquid pharmaceutical composition for the treatment of a posterior eye disease
#903PROTEIN-GRAPHENE NANOCOMPOSITE DRUG CARRIER
#904COMPOSITION FOR THE TREATMENT OF COLD SORES
#905TRANSDERMAL FORMULATIONS OF FLUTICASONE
#906Topical composition containing antioxidants
#907Vaccine formulation for ocular immunization
#908TRANSDERMAL DELIVERY OF SILDENAFIL AND OTHER PHOSPHODIESTERASE TYPE 5 INHIBITORS
#909Methods for preparing squalene
#910Composition for external use on skin for inflammatory diseases
#911Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
#912Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
#913Topical pharmaceutical compositions
#914Transdermal cream
#915Basidiomycete-derived cream for treatment of skin diseases
#916Treatment of endometriosis
#917Compositions of chloro-trifluoropropene and hexafluorobutene
#918TRANSDERMAL FORMULATIONS
#919Methods of treating topical microbial infections
#920Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer
#921Pheromone compositions and their use to modify behavior in different vertebrate species
#922Gel Compositions
#923Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
#924Stable micelles of fatty acid esters for the treatment of disease states
#925Stable micelles of fatty acid esters for the treatment of macular degeneration and primary sclerosing cholangitis
#926Stable micelles of fatty acid esters for the treatment of non-alcoholic fatty liver diseases
#927Stable micelles of fatty acid esters for the treatment of cardiovascular disease
#928Functional foods and kits containing stable micelles of fatty acid esters
#929Stable micelles of fatty acid esters
#930Stable micelles of mixed fatty acids
#931TOPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB
#932Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
#933SOLUBILIZED COQ-10
#934Aerosol formulation for COPD
#935Sterile otic formulations
#936Calcium flux agonists and methods thereof
#937Ropinirole-containing adhesive patch
#938USE OF AN INHIBITOR OF IRS-1 FOR TREATING SKIN DISORDERS
#939DELIVERY OF NAPROXEN AND OTHER COMPOUNDS
#940Method for Separating Components in Natural Oil
#941TOPICAL FORMULATION FOR A JAK INHIBITOR
#942Pharmaceutical Composition
#943Semifluorinated alkane compositions
#944Companion cosmetic compositions
#945Compounds, compositions, and methods for reducing or eliminating bitter taste
#946AZULENE AND DERIVATIVES THEREOF AS COLORANTS
#947Spray delivery device
#948Methods for topical delivery of prostaglandins to subcutaneous fat
#949Composition for forming pluronic-based hydrogel with improved stability
#950Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications
#951Stabilized, sprayable emulsion containing active agent particles
#952Sprayable composition containing zinc oxide and a fluoro-olefin propellant
#953Methods of treating ocular disorders using semifluorinated alkanes
#954Method for treating secondary hyperparathyroidism in CKD
#95517 alpha, 21-dihydroxypregnene esters as antiandrogenic agents
#956Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
#957Process for the production of a submicron oil in water emulsion
#958Patch
#959Vaccine formulations comprising saponin-containing adjuvants
#960Inhalable medicament
#961RESINIFERATOXIN SOLUTION
#962Topical tetracycline compositions
#963Emollients and cosmetic compositions based on specific branched hydrocarbons
#964STABLE PRESSURISED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION
#965Contrast pattern application for three-dimensional imaging
#966TOPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING SUNITINIB
#967TOPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING CEDIRANIB
#968Thrush Treatment Paste
#969USE OF TETRACYCLINE COMPOSITIONS FOR WOUND TREATMENT AND SKIN RESTORATION
#970Patch and method for producing the same
#971Topical Ophthalmological Pharmaceutical Composition containing Axitinib
#972Topical composition comprising a film-forming polymer for delivering an active ingredient to skin
#973Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
#974COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF THREE OR MORE ACTIVE AGENTS
#975O/W-emulsion-type topical pharmaceutical compositions containing a retinoid
#976Anti-infective methods, compositions, and devices
#977AZEOTROPE-LIKE COMPOSITIONS COMPRISING 1-CHLORO-3,3,3-TRIFLUOROPROPENE
#978Topical Formulation Compositions Containing Silicone Based Excipients To Deliver Actives To A Substrate
#979Heparosan-Multimolecular Assembly Drug Delivery Compositions and Methods of Making and Using Same
#980TOPICAL GEL COMPOSITION COMPRISING AN INGENOL DERIVATIVE AND A SOLVENT MIXTURE
#981PHARMACEUTICAL COMPOSITION
#982Oil and liquid silicone foamable carriers and formulations
#983Isoamyl nitrite formulations
#984Compositions for topical delivery of prostaglandins to subcutaneous fat
#985Pharmaceutical compositions for inhalation
#986TRANSDERMAL DELIVERY OF BENEFICIAL SUBSTANCES EFFECTED BY A HOSTILE BIOPHYSICAL ENVIRONMENT
#987Method of making particles for use in a pharmaceutical composition
#988Liquid pharmaceutical formulations for injection comprising procaine and uses thereof
#989Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereof
#990Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereof
#991Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereof
#992Methods for treating polycystic kidney disease
#993Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate
#994Composition and method for inhibiting herpesviridae infections
#995ANTIINFECTIVE FREE INTRAMAMMARY VETERINARY COMPOSITION
#996Method of Using Dihydroergotamine for Pre-emptive Treatment of Migraine
#997INHALER
#998Adjuvant formulations comprising TLR4 agonists and methods of using the same
#999Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
#1000OXYGENATION OF THE MUCOSAL BARRIER BY ENTERAL ARTIFICIAL BLOOD TO PREVENT HYPOXIC BREAKDOWN OF THE MUCOSAL BARRIER
#1001NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF
#1002Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers
#1003NOVEL PROCESS FOR CONCENTRATING SPILANTHOL AND/OR ISOMERS AND/OR HOMOLOGUES THEREOF
#1004Stabilised protein compositions based on semifluorinated alkanes
#1005Topical oil composition for the treatment of fungal infections
#1006COMPOSITIONS FOR THE TREATMENT OF MUCOUS MEMBRANE DISEASES
#1007COMBINATION THERAPY FOR COPD
#1008Methods for controlled release oral dosage of a vitamin D compound
#1009Omega-3 fatty acid ester compositions
#1010Omega-3 fatty acid ester compositions
#1011WOUND TREATMENT DRUG FOR EXTERNAL USE
#1012SMART™ SOLID ORAL DOSAGE FORMS
#1013Medicinal aerosols and methods of delivery thereof
#1014Suspensions of cyclosporin A form 2
#1015Non-irritating testosterone emulsions
#1016TOPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAGENIB
#1017Dihydropyrazoles
#1018Compositions comprising salbutamol sulphate
#1019Composition for external use on skin for inflammatory diseases
#1020Pharmaceutical composition
#1021Carotenoid-containing composition and method for producing same
#1022Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
#1023Vaccine for
#1024Cationic oil-in-water emulsions
#10257-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
#1026Methods for treating diseases using isoindoline compounds
#1027Pharmaceutical topical compositions
#1028Volatile distillate by-product of mint oil that promotes absorption and/or bioavailability of compounds of bio-medical and nutritional interest
#1029Thrush treatment paste
#1030AZEOTROPE-LIKE COMPOSITIONS COMPRISING 1-CHLORO-3,3,3-TRIFLUOROPROPENE
#1031Polychlorinated biphenyls and squalene-containing adjuvants
#1032Suspension type topical formulations comprising cyclic depdipeptide
#10331,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
#1034Tetracycline topical formulations, preparation and uses thereof
#1035Solubilized CoQ-10
#1036Pharmaceutical composition for administration to nails
#1037Solubilized CoQ-10
#1038TOPICAL UBIQUINOL SUPPLEMENT SKIN CARE COMPOSITIONS
#1039COMPOSITIONS AND METHODS OF FORMING FILMS FOR IMPROVED DRUG DELIVERY
#1040Topical pharmaceutical composition based on semifluorinated alkanes
#1041Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
#1042Pharmaceutical composition and methods for peptide treatment
#1043Compositions, gels and foams with rheology modulators and uses thereof
#1044EMULSIONS OF PERFLUOROCARBONS
#1045Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
#1046Saccharide conjugates
#1047Oil-based foamable carriers and formulations
#1048Glycopeptide phosphonate derivatives
#1049Stabilized carotenoid compositions
#1050O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES
#1051TOPICAL MIXTURE AND METHOD FOR DERMAL APPLICATION TO REMOVE EXCESS IRON AND OTHER HEAVY METALS FROM CELLULAR TISSUE
#1052Compositions for transdermal delivery of active agents
#1053CAROTENOID PARTICLES AND USES THEREOF
#1054Antimicrobial compositions and methods
#1055Liquid pharmaceutical composition for the treatment of a posterior eye disease
#1056CAROTENOID COMPOSITIONS CONTAINING OCTENYL SUCCINATE ANHYDRIDE-MODIFIED GUM ACACIA
#1057Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
#1058Liquid pharmaceutical composition for the delivery of active ingredients
#1059Pheromone compositions and methods of use
#1060Contrast pattern application for three-dimensional imaging
#1061Method for preventing or treating skin tumor
#1062Azeotrope-like compositions comprising 1-chloro-3,3,3-trifluoropropene
#1063Methods for accelerated return of skin integrity and for the treatment of impetigo
#1064Topical pharmaceutical compositions for treatment of skin damage
#1065ORAL PHARMACEUTICAL FILM FORMULATION FOR BITTER TASTING DRUGS
#1066Methods for preparing squalene
#1067Paraffin Wax Embedded Drug Delivery System
#1068Topical skin composition comprising shea butter, jojoba oil, petroleum jelly, glycerin, and zinc oxide
#1069Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
#1070Otic formulations, methods and devices
#1071Dihydropyrazoles
#1072Antimicrobial compositions
#1073LOTIONS DERIVED FROM RENEWABLE RESOURCES AND ABSORBENT ARTICLES COMPRISING SAME
#1074Method for separating components in natural oil
#1075Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time
#1076Compositions and methods for treating influenza
#1077Nutritional composition
#1078Compounds, compositions, and methods for reducing or eliminating bitter taste
#1079Delivery system for biological component
#1080Preparation for use in opthalmology and retinal surgery
#1081MICROBUBBLE COMPLEXES AND METHODS OF USE
#1082Arylamide compounds and compositions and uses thereof
#1083Antimicrobial composition and uses thereof
#1084Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
#1085COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES
#1086Evaporation operative materials having low environmental impact
#1087Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
#1088Pharmaceutical composition for treatment of increased intraocular pressure
#1089Topical tetracycline compositions
#1090DRUG DELIVERY SYSTEM FOR TREATMENT OF LIVER CANCER BASED ON INTERVENTIONAL INJECTION OF TEMPERATURE AND pH-SENSITIVE HYDROGEL
#1091Method of making composite particles for use in pharmaceutical compositions and composite particles and compositions thereof
#1092TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM
#1093COMPOSITION FOR TREATING DECUBITUS ULCERS IN DIABETIC AND NON-DIABETIC PATIENTS
#1094Surfactant-free, water-free formable composition and breakable foams and their uses
#1095NANOPARTICLE COMPOSITIONS AND COMPONENTS THEREOF
#1096CUTANEOUS COMPOSITION COMPRISING VITAMIN D ANALOGUE AND A MIXTURE OF SOLVENT AND SURFACTANTS
#1097COMPOSITIONS FOR ORAL USE AND METHODS FOR TREATING THE ORAL MUCOSA, LIPS, AND PERIORAL REGIONS
#10981,3-disubstituted 4-(aryl-X-phenyl)--pyridin-2-ones
#1099Glycopeptide phosphonate derivatives
#1100Suspension type topical formulations comprising cyclic depsipeptide
#1101Composition of special fluid and use
#1102USE OF A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING HEART FAILURE AND ARRHYTHMIA IN POST-MYOCARDIAL INFARCTION PATIENTS
#1103Combination composition comprising benzoyl peroxide and adapalene
#1104COMPOSITIONS OF OPIOID ANTAGONISTS AND METHODS FOR TREATING SCLERODERMA THEREWITH
#1105METHOD FOR TREATING VITILIGO WITH A PROSTAGLANDIN ANALOGUE
#1106Pharmaceutical composition for treatment of dry eye syndrome
#1107COMBRETUM LAURIFOLIUM MART. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT
#1108Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
#1109Use of an oleogel containing triterpene for healing wounds
#1110Semisolid aqueous pharmaceutical composition containing tapentadol
#1111TABLET MANUFACTURE
#1112Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications
#1113Topical compositions comprising ascomycins
#1114Nanocarriers for imaging and therapy applications
#1115Polychlorinated biphenyls and squalene-containing adjuvants
#1116Androgen composition for treating an opthalmic condition
#1117Use of non-digestible oligosaccharides
#1118PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS INCLUDING INHIBITORS OF THE PLECKSTRIN HOMOLOGY DOMAIN AND METHODS FOR USING SAME
#11197-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
#1120Topical Formulation Containing a Tetracycline and a Method of Treating Skin Infections Using the Same
#1121Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
#1122Formulations of volatile anesthetics and methods of use for reducing inflammation
#1123ANTIFUNGAL FORMULATIONS
#1124Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene
#112517ALPHA, 21-DIHYDROXYPREGNENE ESTERS AS ANTIANDROGENIC AGENTS
#1126Topical composition containing naproxen
#1127Pharmaceutical composition for treating dermatological autoimmune diseases
#1128Trazodone and trazodone hydrochloride in purified form
#1129MEDICINAL ANTIDIAPER RASH CREAM INCORPORATING A BIOPOLYMER AND A PROCESS TO MAKE IT
#1130Solubilized CoQ-10
#1131Azeotrope-like compositions comprising 1-chloro-3,3,3-trifluoropropene
#1132Topical Compositions Comprising Inorganic Particulates And An Alkoxylated Diphenylacrylate Compound
#1133Solubilized CoQ-10
#1134Immunogenic compositions containing phospholipid
#1135Process and apparatus for producing hydrocarbons by hydrogenating a terpene feed
#1136TRANSDERMAL DELIVERY OF BENEFICIAL SUBSTANCES EFFECTED BY A HOSTILE BIOPHYSICAL ENVIRONMENT
#1137Crystalline pharmaceutical and methods of preparation and use thereof
#1138Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions
#1139Method for keeping an immunogenic composition available for administration to an animal
#1140COMBINATION TREATMENT FOR ROSACEA
#1141Anti-fibroblastic fluorochemical emulsion therapies
#1142COMBINATION TREATMENT FOR DERMATOLOGICAL CONDITIONS
#1143Compositions and Methods for the Treatment of Soft Tissue Injury
#1144AZEOTROPE-LIKE COMPOSITIONS COMPRISING 1-CHLORO-3,3,3-TRIFLUOROPROPENE
#1145Azeotrope-like compositions comprising 1-chloro-3,3,3-trifluoropropene
#1146Particulate materials
#1147STABLE PHARMACOLOGICALLY ACTIVE COMPOSITIONS INCLUDING VITAMIN D CONTAINING AND CORTICOSTEROID COMPOUNDS WITH LOW pH COMPATIBILITY
#1148Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
#1149PHARMACEUTICAL COMPOSITION COMPRISING GLYCEROL, WHITE SOFT PARAFFIN AND LIQUID PARAFFIN FOR THE TREATMENT OF UREMIC XEROSIS AND/OR PRURITUS
#1150Combination of compounds for treating or preventing skin diseases
#1151Pharmaceutical compositions for dehydrating, atrophying and eliminating pathological tissues
#1152Medicinal Cream Made Using Fluticasone Propionate And Chitosan And A Process To Make The Same
#1153STABLE PHARMACOLOGICALLY ACTIVE COMPOSITIONS INCLUDING VITAMIN D-CONTAINING AND CORTICOSTEROID COMPOUNDS WITH LOW pH COMPATIBILITY
#1154Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
#1155TREATMENT AND PREVENTION OF BENIGN PIGMENTED MOLES (NAEVI) USING ARTEMISININE AND THE DERIVATIVES THEREOF
#1156Method for treating secondary hyperparathyroidism in CKD
#1157Chemical Combination and Method for Increasing Delivery of Coenzyme Q10
#1158TOPICAL FORMULATION FOR A JAK INHIBITOR
#1159Compositions, gels and foams with rheology modulators and uses thereof
#1160Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
#1161Antiinfective free intramammary veterinary composition
#1162Oil-based foamable carriers and formulations
#1163Pharmaceutical topical compositions
#1164C-19 steroids for specific therapeutic uses
#11651-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
#1166Topical skin composition comprising shea butter, jojoba oil, petroleum jelly, stearic acid, magnesium sulfate, zinc oxide, glycerin, and water
#1167Permeable mixtures, methods and compositions for the skin
#1168Stabilized composition for treating psoriasis
#1169Tacrolimus preparation for external applications
#1170Vaccine for shigella
#1171Oil and liquid silicone foamable carriers and formulations
#1172Treatment For Neuropathy, Shingles And Related Disorders
#1173PHARMACEUTICAL COMPOSITION
#1174Skin Penetration Enhancing Systems for Polar Drugs
#1175Methods for producing vaccine adjuvants
#1176Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues
#1177Pheromone compositions and methods of use
#1178COMBINATION THERAPY FOR COPD
#1179AEROSOL FORMULATION FOR COPD
#1180Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
#1181Vaccine formulations comprising saponin-containing adjuvants
#1182Composition of bifonazole and its use
#1183Pharmaceutical Compositions and Solid Forms
#1184Conveniently implantable sustained release drug compositions
#1185Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound
#1186Stable Topical Formulation Comprising Voriconazole
#1187Technique for drug and gene delivery to the cell cytosol
#1188Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives
#1189Composition for external application comprising transcription factor decoy as active ingredient
#1190COMPOSITIONS COMPRISING ADJUVANT, MACROLIDE AND PROTEINACEOUS ANTIGEN AND METHODS OF USE THEREOF
#1191Low ether compositions and delivery apparatus
#1192Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance
#1193Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
#1194Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
#1195ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
#1196Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
#1197Medicament for the treatment of viral skin and tumour diseases
#1198Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
#1199TOPICAL COMPOSITION CONTAINING THE COMBINATION OF MUPIROCIN AND BECLOMETHASONE
#1200Fentanyl-containing patch for external use